James T. Borello RIA’s Jazz Pharmaceuticals JAZZ Stock Holding History

James T. Borello RIA’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.03K	Buy	39 +1	+3%	+$247	﹤0.01%	629
2026 Q2	$9.16K	Hold	38	–	–	﹤0.01%	623
2026 Q1	$7.18K	Hold	38	–	–	﹤0.01%	662
2025 Q4	$6.46K	Buy	38 +33	+660%	+$5.06K	﹤0.01%	511
2025 Q3	$659	Buy	+5	New	+$600	﹤0.01%	846

Other funds holding JAZZ

ACM

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

James T. Borello RIA's JAZZ Position: Q3 2026 in Review

James T. Borello RIA increased its Jazz Pharmaceuticals (JAZZ) stake by 2.6% in Q3 2026, buying an estimated $247 and bringing the position to 39 shares worth $9.03K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

James T. Borello RIA first reported a position in JAZZ in Q3 2025 and has held it in 5 quarters since. The position peaked at $9.16K in Q2 2026. 68 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

James T. Borello RIA held 39 shares of Jazz Pharmaceuticals worth $9.03K as of Q3 2026.
James T. Borello RIA bought 1 Jazz Pharmaceuticals share in Q3 2026, an estimated $247.
Jazz Pharmaceuticals made up ﹤0.01% of James T. Borello RIA's portfolio in Q3 2026, its #629 holding.
James T. Borello RIA first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
James T. Borello RIA's Jazz Pharmaceuticals position peaked at $9.16K in Q2 2026.
68 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on James T. Borello RIA's 13F filing for Q3 2026, filed 16 Oct 2026.